This research work explores the surface chemistry and drug-polymer interaction in the manufactured controlled release micro-particles. Isoniazid (INH) was used as a model antitubercular drug while Eudragit® S100 (S100), Eudragit®L100-55 based co-processed Acryl EZE (EZE) and Ethylcellulose ECN10 (ECN10) were used as polymeric carriers. INH containing micro-particles were prepared using a mini spray dryer B-290 (Buchi, Switzerland). The drug polymer ratios were optimized at 1:1 and 1:3 to evaluate the effect of polymers on the release of the drug from the micro-particles. Solid state characterization via SEM and particle size analysis of the manufactured micro-particles showed densely aggregated spherical particles with a mean diameter less than 10 µm. The advanced surface analysis via EDS revealed a homogenous drug distribution on the spray dried micro-particles.
'Microencapsulation' via spray drying process is referred to a technique in which a drug in the form of a solid or liquid is encapsulated in a biocompatible and/or biodegradable polymeric matrix or pharmaceutically acceptable excipients [1] . Generally, by means of this process, the produced particles are with a diameter in the range of 1 to 1000 micrometers [1] .
Microencapsulation technique has various pharmaceutical applications such as preparation of sustained or prolonged release medications, single layer tablet containing chemically incompatible ingredients and new formulation concepts for creams, aerosols, plasters, surgical dressings, injectable [2] [3] [4] [5] . In the case of drugs that are poorly water soluble, microencapsulation process is carried out to achieve its increased dissolution rate with a fast onset of action [1, 5] . In recent years, microencapsulation process using spray drying technique has become quite popular due to its industrial adaptability and ease of scale up process meeting the regulatory requirements [1] [2] [3] [4] [5] .
Spray drying is, in general term, the transformation of feed (solution, suspension or emulsion) from a fluid state into a dried particulate form by means of spraying the feeding solutions into a hot drying medium (cyclone). Spray drying is a unique process whereby the final product complies with the standards concerning particle size, particle size distribution, particle shape, moisture content and bulk density in a single step operation [1, 3, 5, [6] [7] [8] [9] [10] .
Due to rapid solvent evaporation, spray drying is widely used in the drying of foodstuffs, pharmaceuticals, ceramics and many other substances. The most important aspect of spray drying is the automization of suspension into hot drying medium (usually air). The formation
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5 of a fine spray due to automization is the most important factor to gain economic production of top quality products, by maintaining optimum conditions for evaporation [1, [6] [7] [8] [9] [10] [11] [12] .
Controlled release drug delivery systems are aimed at achieving more predictable bioavailability of drugs and help in optimizing pharmaco-therapies. As compared to conventional dosage forms, these systems provide improved efficacy, reduced side effects and avoid issue with the patient compliances [2] [3] [4] . Out of all dosage forms such as tablets or capsules, microparticles have significant advantages such as protection of drug from the gastrointestinal tract by administrating through intramuscular or subcutaneous route, ease of administration, target specific drug delivery and no need for surgery to remove empty remnants [1, 2, 5] .
Polymers can be used for the purpose of prolonging the release and in turn bioavailability by encapsulating the active ingredient in the polymeric matrix or shell.
Various polymers such as Eudragit polymers, cellulose derivatives and some natural polymers have been successfully used in the preparation of delivery systems by spray drying.
The success of the process depends on a number of factors such as the type of feed, the degree of core material encapsulation and the drug/polymer ratio [13, 14] .
Isoniazid (INH) is a first line antitubercular drug used for the prophylaxis and therapy of tuberculosis caused by mycobacterium tuberculosis. The most probable mechanism of action of isoniazid is the inhibition of synthesis of mycolic acids which is a unique component of mycobacterium cell wall [15, 16] . Due to its pharmacokinetics and pharmacological properties, controlled release dosage forms of INH are prepared so that it would maximize therapeutic efficacy, reduce dosing intervals and dose related adverse effects [16] . INH is soluble in water (~14% at 25ºC, ~26% at 40ºC), with a pKa value of about 1.82
and Log P 0.64, LD 50 100 mg/kg (Human, oral) [16, 17] .
The aim of this study was to optimize and prepare INH loaded microparticles by means of spray drying techniques. For the first time, an EDS and XPS were combined to study the surface chemistry of the spray dried particles. The novelty of this reported study lies on the exploitation of novel EDS and XPS techniques to analyse the surface of the manufactured micro-particles and outline chemical interactions between the drug and polymers, respectively. Organic dispersions of either Eudragit S100 and Acryl EZE or ethyl cellulose derivatives with various drug/polymer ratios were evaluated to develop controlled release drug delivery systems of INH.
Materials and Method

Materials
Isoniazid (INH) was purchased from Sigma Aldrich (Gillingham, UK). The polymers Ethyl Cellulose N10 (ECN10) was kindly donated by Harkeulus (Germany). Eudragit S100 (S100) and Eudragit L100-55 based co-processed polymer Acryl-EZE (EZE) was kindly provided by Evonik Industries (Germany) and Colorcon Ltd (Dartford, UK), respectively.
Absolute ethanol and other solvents for HPLC were of laboratory/pharmaceutical grade and obtained from Fisher scientific (UK).
Spray drying process
The microencapsulation process was performed in a B-290 mini spray dryer (Buchi, Basel, Switzerland). Various drug/polymer binary mixtures (1:1 and 1:3) were dissolved in ethanol (100 mL) as shown in Table 1 . The processing parameters for all spray drying processes are also summarized in Table 1 . Briefly, the inlet temperature was set at 100 Bulk and tap densities of the spray dried powder were also measured by taking about 1 g of sample and placing it in a 10 mL measuring cylinder. The initial reading was taken as volume. The powder in the cylinder was tapped 100 times onto a rubber mat with the help of a Tap Machine. This process was repeated 3 times. The final reading of the cylinder was then recorded and the tap density was calculated. 
Particle size analysis
The particle size distributions of all spray dried powders were determined using a 
Scanning Electron Microscopy (SEM)/ EDS analysis
Micrographs of pure drugs and spray dried powders were obtained by a scanning electron microscopy using a JEOL JSM-5310LV machine (JEOL, Tokyo, Japan) at 15kV accelerating voltage, 20 mm working distance, spot size 14, secondary electron detector.
Elemental assays and mapping were also undertaken using an AZtec Energy Dispersive Xray microanalysis system with 50 mm 2 X-Max detector (EDS) (Oxford Instruments, UK). For the purpose of the analysis, all samples were placed on double sided adhesive carbon tapes stuck on aluminium stubs. All samples were then coated with a thin layer of carbon by using an Edwards 306 high vacuum carbon evaporator prior to each analysis.
X-Ray Powder Diffraction (XRPD)
For XRPD studies a Bruker D-8 Advance (Germany) system was used. The experiment was carried out at an angle of 2-40 2-theta values. The sample was rotated at 15 rpm and the exit slit used was 0.2 mm. The opening angle was 3 0 . The generator condition was set at 40 kv and 40 mA. The counting time was 0.1 seconds per step. Lynex Eye controller was used.
Differential Scanning colorimetry
The solid state of the pure drug, polymers and the spray dried powders was studied using a differential scanning colorimetry ( STARe thermal analysis software was used for data analysis.
X-ray photoelectron spectroscopy (XPS)
The XPS was performed to analyze the first layer atomic structure of the formulations via a Kratos Axis Ultra-DLD using a monochromatic Al K α X-ray source (120 W) and an analyzer pass energy of 160 eV (survey scans) or 20 eV (high resolution scans). The operating pressure during analysis was optimized at 1×10 -9 Torr. The C (1s) signal at 285.0 eV was used as a reference signal for all data and was attributable to unsaturated C-C/C-H bonds. CasaXPS TM (Version 2.3.15) software was used for the quantification and curve fitting of all formulations run in the XPS analysis.
Dissolution studies
The dissolution studies were performed using Varian 705 DS. The temperature of the dissolution bath was maintained at 37 o C and the stirring rate at 100 rpm. The dissolution medium used was 750 ml 0.1 N HCl solution of pH 1.2 for first two hours. The pH was then changed to 6.8 by using 150 ml phosphate buffer after 2 h. The spray dried samples of about 100 mg equivalent of INH was used in each vessel. About 2-3 ml samples were withdrawn at an interval of 0.5, 1, 2, 3, 5 and 12 h and filtered prior to collect them in airtight glass vials.
All samples were run in triplicates (n=3).
High Performance Liquid Chromatography (HPLC)
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The released INH amount was determined by using HPLC 1200 series (Aligent Technologies) and detected at 266 nm using a variable wavelength detector. The column used was HICHROM H50DS 3801 and the mobile phase methanol: water (60:40). The flow rate was maintained at 1.5 ml/min. various standard solution ranging 10-50 µm/ml were used to plot a calibration curve and calculated the drug release profile of INH.
Release mechanism
Zero order kinetics, first order kinetics, Hixson-Crowell, Higuchi and Korsmeyer-Peppas models were used for the analysis of the dissolution mechanism taking the rate constant obtained from these models as an apparent rate constant. The drug release patterns were analysed by release kinetics theories using a software suite DDSolver [18] .
Statistical analysis
The samples were compared with the reference (control) by an analysis of variance (ANOVA) test. The Microsoft Excel (MS 2013, USA) software was used to perform all statistical analyses. The P-value < 0.05 was considered as significant. All the results are expressed as mean ± standard deviation.
Results and Discussion
Spray drying processing
Various parameters used to manufacture microencapsulated particles of isoniazid/polymers using the spray drying processing as well as the drug loading and encapsulation efficiency are summarized in Table 1 . All drug and polymers used in this study were polar in nature and depicted in Figure 1 . The difference in the yield was observed in the case of different polymers and formulations and some portion of the product was lost due to either the exhaust gas in the cyclone or some product being adhered to the cyclone. The highest yield was obtained in the case of ethyl cellulose derivatives (EC 10) with different
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A C C E P T E D M A N U S C R I P T 11 drug/polymer ratios. As can be seen in Table 1 Generally, it is expected that a high drying or inlet temperature will result in a faster drying rate leading to a higher productivity of the spray dried powders. Since the drying temperature used in this study was relatively high (100 o C) in the presence of organic solvents, the percentage yield of all formulations was satisfactorily above the average (50-60%) that typically achieved in a spray drying technique. It has been reported in the literature that the high air inlet temperature normally causes an excessive evaporation and cracks the membrane resulting in high amount of encapsulated ingredients collected [2, 19] . Similarly, the drying rate applied in this study produced the higher ratio of surface to volume for the spray-dried particles resulting in the lower density of the powders (Table 2 ) [20] . Calculated bulk and tap density results for all spray dried formulations are represented in Table 2 
Particle morphology and surface analysis
The micrographs of INH loaded formulations revealed spherical shaped particles ( Interestingly, it has been seen that a large number of particles fell in the nano-sized range which may prove efficient for developing some drug molecule to overcome solubility issues.
A further analysis of SEM/EDS undertaken to elucidate the presence and distribution of the drug particles in the spray dried polymeric matrices showed a homogenous distribution of the drug throughout. From the structural analysis of the drug and the polymers used as shown in Fig. 1 , only the drug has nitrogen (N) atoms in its structure while both polymers are made of mainly O and C. Therefore, an elemental analysis of N atoms in all spray dried particles will indicate the homogeneity of the drug distribution. Therefore, for the purpose of this study, N atoms were used as a marker to confirm the presence of the drug in the ACCEPTED MANUSCRIPT
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13 microencapsulated polymeric matrices. The distribution of the drug was experimented by implementing the EDS elemental mapping of N atoms (Fig. 2b) . The EDS mapping showed that majority of the area was covered by the O and C which was expected as most of the organic drugs and polymers are composed of mainly these two atoms, likewise the drug and the polymers used in this study. As results of this, in all spray dried particles, the amount of N present comprised comparatively the least proportion of all of the other elements.
As depicted in showed complementing results compared to that of pure INH. The foregoing is supported by the literature as well [21, 22] .
XRPD studies
The crystallinity of the drug in the microencapsulated particles was analyzed by Xray diffraction. As can be seen in Fig. 3 , the diffractogram of pure INH exhibited major distinct intensity peaks at various 2-theta positions ranging from 10 to 30 2θ degrees while the polymers (S100 and ECN10) exhibited peaks due to their amorphous nature. However, the co-processed Acryl EZE showed some characteristic peaks due to the presence of crystalline materials in the structure (data not shown). The spray dried micro-nano particles showed identical low intense peak due to the presence of crystalline INH in the formulations.
The reduction in the intensity of the crystallinity indicated the increase in the amorphicity of the drug present in the spray dried powders. Apparently, it has been seen that the increase in
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Thermal analysis
The solid state of the drug, bulk polymer and the formulations were studied by the DSC. Fig. 4a depicts the DSC traces of the pure drug and the polymers. The highly crystalline (crystallinity higher than 92%) INH showed a sharp thermal endothermic event at 
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Surface elemental analysis via XPS
Advanced application of XPS to outline the first layer atomic structures of the bulk drug, polymers and the spray dried particles was implemented based on the hydrogen consumption approach. The chemical elemental surveys of the drug, polymer and active formulations are depicted in Fig. 5a . It shows that the drug contains about 54% of C while 17% O and about 34% N. The elemental ratios are in in good agreement with that of theoretically calculated values. In contrast, S100 predominantly contained 75% C while EZE contained O, C, Mg and Si as it is a co-processed polymer with crystalline substances and silica/Talc.
The peak fitting and data interpretation using the CasaXPS software determined the N (1s) binding energy (BE) at ~399.3 eV and ~402.0 eV corresponding to the two different N environments present in the INH structure (Fig. 5b) . These two different N atoms may contribute to different types of protonation effects. The ratio between the two N environments may prove significantly important to determine and possibly outline the interactions between the drug and the anionic polymers.
The N (1s) BE values of ~402.0 eV in INH indicates the protonation effects of the NH + group. Interestingly, this has been shifted to ~402.7 eV in S100 system and ~402.9 eV for EZE (Fig. 5b) . Apparently, these significant shifts in the BE values of N atoms are attributed to the interactions of the drug and the respective polymers. These also are due to the heavy protonation effect of N atoms in the spray dried particles resulting in the interaction via the amide group of the drug and the carboxyl group of the polymers [24] [25] [26] . The calculated low N coefficient values in the formulations revealed that the interactions between the drug and polymers are quite strong. It has been reported that the lower N coefficient value leads to a high number of protonated N atoms that take part in the interactions making it stronger [27] [28] [29] [30] .
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In vitro dissolution studies
The main aim of this study was to evaluate the drug release behavior of the manufactured spray dried microencapsulated particles as INH is highly water soluble drug the release rate is very fast (>80% release in 1 h) [31] . The in vitro dissolution results are shown in Figures 6a and 6b . The drug/polymer ratio of 1:1 with three different polymers showed a different controlled release pattern for the first 2 h and then a burst release when the pH was increased to 6.8 (Fig. 6a ). This could highly be attributed to the pH dependent dissolution of anionic S100 and EZE polymers. It has been reported that none of these polymers dissolved at pH below 6-6.5 [32] . In contrast, when ECN10 was used as the polymeric carrier, a relatively faster drug release was observed due to the pH independent dissolution of the polymer.
Interestingly, when the polymer content was increased in the formulations (drug:
polymer ratio 1:3), the drug release seemed to reduce (Fig. 6b) due to the increased amount of the release retarding polymers which played a pivotal role to slow down the release of the highly soluble drug. Formulations containing S100, generally, showed a very slow release profile throughout the study for 12 h while for EZE, a faster release was observed when the pH was increased from 1.2 to 6.8 after 2 h. This could be due to the co-processed nature of the polymer and a bit lower pH dependency. Regardless of the formulation compositions, the release of the drug from all spray dried particles were controlled which proves the effective role of these polymers to develop controlled release formulations via spray dried encapsulation technique. ANOVA statistical test showed that for the same polymer the ratio of drug: polymer ratios have no significant effects on the drug release (p>0.05).
Release mechanism studies
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The kinetic parameters derived from the various release kinetic models of the INH release are summarized in Table 3 . The analysis of the correlation coefficient (R 2 ) in all models used indicated that the maximum R 2 was found in the First Order release kinetics model. Therefeore, analyses performed by DDSolver software revealed that the drug release mechanism followed a first order release kinetics (Table 3) for all of the formulations prepared.
Conclusions
A spray drying process was successfully implemented for the microencapsulation of isoniazid which proved a promising approach to develop controlled release dosage forms.
The microscopic investigation showed that the obtained micro-particles were spherical in shape and a mean particle size less than 10 microns. The solid state analysis revealed the existence of the semi crystalline INH in the polymer matrices. The advanced surface analysis conducted by using EDS showed a homogeneous distribution of the drug in the polymeric spray dried particles while the first layer elemental analysis via XPS revealed a strong intermolecular interaction between the drug and the polymer used in all formulations. In addition, the manufactured particles showed a controlled (pH dependent) release of the soluble INH which proves that this emerging processing technology can successfully be implemented to develop modified release solid dosage forms.
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Figure 2b
EDS mapping of bulk INH and the INH/S100 formulations. 
Figure 5a
Chemical elemental surveys conducted via XPS using CasaXPS software.
Figure 5b
Peak fitting of N (1s) binding energy of the drug and the spray dried particles with S100 and EZE polymers.
Figure 6
In vitro dissolution studies of INH pure and the spray dried micropartciles at (a) drug/polymer 1:1 ratio and (b) drug/polymer 1:3 ratio (n=3).
